Skip to main content

Clinical Trials › NCT03535298

Active, Not RecruitingPhase 4

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

Sponsored by The Cleveland Clinic

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
800
Target enrollment
8
U.S. states
Jan 2019
Start date
Jul 2027
Expected completion

Interventions / Treatments

Early Highly Effective Therapies GroupEscalation Therapies Group

Conditions studied

Multiple Sclerosis, Relapsing-Remitting

Where this trial is running (15 sites)

Ohio3 sites
Cincinnati · Cleveland · Columbus
Texas3 sites
Austin · Houston · Houston
Minnesota2 sites
Minneapolis · Rochester
New York2 sites
Buffalo · Rochester
Virginia2 sites
Charlottesville · Richmond
Colorado1 site
Aurora
Nevada1 site
Las Vegas
Wisconsin1 site
Madison

MS centers in Ohio

Compare treatment centers near a trial site by center type, providers and trials.

View Ohio centers

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play